Syndax Pharmaceuticals Inc (SNDX)
22.05
+0.19
(+0.87%)
USD |
NASDAQ |
May 03, 16:00
22.04
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Free Cash Flow: -160.60M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -160.60M |
| September 30, 2023 | -142.15M |
| June 30, 2023 | -126.04M |
| March 31, 2023 | -130.97M |
| December 31, 2022 | -133.68M |
| September 30, 2022 | -10.07M |
| June 30, 2022 | -6.472M |
| March 31, 2022 | 9.789M |
| December 31, 2021 | 29.13M |
| September 30, 2021 | -87.21M |
| June 30, 2021 | -80.56M |
| March 31, 2021 | -77.92M |
| December 31, 2020 | -71.26M |
| September 30, 2020 | -68.36M |
| June 30, 2020 | -58.59M |
| March 31, 2020 | -49.71M |
| December 31, 2019 | -50.61M |
| September 30, 2019 | -52.93M |
| June 30, 2019 | -62.87M |
| March 31, 2019 | -65.49M |
| December 31, 2018 | -68.72M |
| Date | Value |
|---|---|
| September 30, 2018 | -66.42M |
| June 30, 2018 | -58.18M |
| March 31, 2018 | -54.83M |
| December 31, 2017 | -47.46M |
| September 30, 2017 | -45.11M |
| June 30, 2017 | -46.39M |
| March 31, 2017 | -41.55M |
| December 31, 2016 | -35.42M |
| September 30, 2016 | -29.33M |
| June 30, 2016 | -23.02M |
| March 31, 2016 | -20.06M |
| December 31, 2015 | -2.477M |
| September 30, 2015 | -1.626M |
| June 30, 2015 | 0.967M |
| March 31, 2015 | 1.164M |
| December 31, 2014 | -14.39M |
| September 30, 2014 | -13.70M |
| June 30, 2014 | -13.24M |
| March 31, 2014 | -10.32M |
| December 31, 2013 | -7.295M |
Free Cash Flow Range, Past 5 Years
-160.60M
Minimum
Dec 2023
29.13M
Maximum
Dec 2021
-70.06M
Average
-68.36M
Median
Sep 2020
Free Cash Flow Benchmarks
| SpringWorks Therapeutics Inc | -244.89M |
| Alnylam Pharmaceuticals Inc | 127.82M |
| Geron Corp | -184.70M |
| Ionis Pharmaceuticals Inc | -335.52M |
| Madrigal Pharmaceuticals Inc | -325.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -41.35M |
| Cash from Investing (Quarterly) | -16.29M |
| Cash from Financing (Quarterly) | 258.48M |
| Free Cash Flow Per Share (Quarterly) | -0.57 |
| Free Cash Flow Yield | -10.35% |